agreed. i got a fright when i saw this aftermarket but looks like good progress on all fronts. For me, at this market cap, the phase 3 study with statistically robust efficacy from phase 2 is the main game. no brainer really.
seems like lots of really interesting stuff happens during the quarter that other biotechs would announce as material events.
agreed. i got a fright when i saw this aftermarket but looks...
-
- There are more pages in this discussion • 10 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add TRP (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
42.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $25.39M | |||
| Open | High | Low | Value | Volume |
| 41.5¢ | 43.0¢ | 39.0¢ | $102.0K | 248.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 352 | 40.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 41.5¢ | 1500 | 1 |
View Market Depth
| Last trade - 15.44pm 30/08/2024 (20 minute delay) ? |
| TRP (ASX) Chart |